Copyright
©The Author(s) 2015.
World J Gastroenterol. Jul 7, 2015; 21(25): 7730-7741
Published online Jul 7, 2015. doi: 10.3748/wjg.v21.i25.7730
Published online Jul 7, 2015. doi: 10.3748/wjg.v21.i25.7730
Table 4 Combined effect of polymorphisms TLR2 -196 to -174 del, TLR4 +896 A/G and TLR4 -1607 T/C on the risk of colorectal carcinoma
| Risk genotypes | C | CRC | OR (95%CI) | P value |
| n = 240 | n = 188 | |||
| None | 104 | 136 | 1.00 (reference) | |
| TLR2 ins/del or del/del TLR4 +896 A/G | 4 | 3 | 0.98 (0.21-4.48) | 1.000 |
| TLR2 ins/del or del/del TLR4 -1607 T/C or C/C | 11 | 11 | 1.31 (0.54-3.13) | 0.650 |
| TLR4 +896 A/G/ | 2 | 2 | 1.31 (0.18-9.44) | 1.000 |
| TLR4 -1607 T/C or C/C |
-
Citation: Proença MA, de Oliveira JG, Cadamuro ACT, Succi M, Netinho JG, Goloni-Bertolo EM, Pavarino &C, Silva AE.
TLR2 andTLR4 polymorphisms influence mRNA and protein expression in colorectal cancer. World J Gastroenterol 2015; 21(25): 7730-7741 - URL: https://www.wjgnet.com/1007-9327/full/v21/i25/7730.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i25.7730